Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...
On January 14, iFX EXPO Dubai 2025, the leading online trading event in MENA, kicked off a dynamic 2+ days of FX and Fintech ...
CAMBRIDGE, Mass. - Scholar Rock (NASDAQ: SRRK), a biopharmaceutical company with a market capitalization of $3.96 billion and an impressive 362.73% stock price surge over the past six months, ...
On the 14th of January, iFX EXPO Dubai 2025, MENA’s #1 online trading industry event, kicked-off its remarkable 2+ days of FX ...
Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...
With this approval, patients who receive the anti-amyloid drug biweekly for 18 months can then consider switching to a monthly dosing regimen.
The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...
ONS-5010 (bevacizumab-vikg) was found to be noninferior to ranibizumab for neovascular age-related macular degeneration at week 12.
Explore the case of Joanne Chesimard, also known as Assata Shakur, a controversial figure convicted of killing a New Jersey ...
Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the FDA has ...
Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the U.S. FDA has ...